ClinicalThought

Share

Program Content

Activities

  • Novel BTKi for CLL/SLL
    Our Experiences and Considerations With Current and Emerging BTK Inhibitors for R/R CLL/SLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 26, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from Lilly and Merck Sharp & Dohme, LLC.

Lilly

Merck Sharp & Dohme, LLC